[Edaily Reporter Kwon Oh Seok ] The Financial Supervisory Service announced on the 9th that it had issued a correction order to HUMAX CO., LTD.(115160)and Humax Holdings Co., Ltd(028080)regarding their merger decision, citing significant omissions or false statements in the Key Facts Report and Securities Registration Statement—specifically concerning important matters related to investment decisions. Previously, HUMAX CO., LTD. had pursued an absorption merger with its holding company, Humax Holdings Co., Ltd., to address the risk of delisting due to its low market capitalization.
Disclosure Plus
FSS Puts the Brakes on HUMAX CO., LTD. and Humax Holdings Co., Ltd. Merger… Issues Correction Order
Kwon Oh Seok
2026-07-09 17:18:13
Economy
Corporation
IT·Science
Economy
NEXTBIOMEDICAL CO., LTD., Which Made Its Mark Globally with NexPowder, Named a “KOSDAQ Rising Star” for the Second Consecutive Year
#NEXTBIOMEDICAL CO., LTD., a company specializing in innovative medical devices, has been named to the Korea Exchange’s “KOSDAQ Rising Star” list for the second consecutive year, once again demonstrat…
Corporation
Remedi Surges 23%; Bio Solution Climbs on China Expansion [K-bio pulse]
Portable X-ray manufacturer Remedi saw its stock price surge after reporting explosive earnings growth. The company is expanding rapidly not only in South Korea but also overseas, raising expectations…
IT·Science
LGCHEM,LTD Begins Preclinical Trials for ‘GNV205,’ an Immunotherapy Drug Based on Genube Technology
#
LGCHEM,LTD is set to begin preclinical research on “GNV205,” an antibody-cytokine fusion candidate acquired from the domestic biotech firm GenuV. The company plans to develop it as a next-gen…
